SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000921895-21-001172
Filing Date
2021-04-29
Accepted
2021-04-29 16:35:22
Documents
3
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 def14a12566010_04292021.htm DEF 14A 309632
2 GRAPHIC proxycard01a.jpg GRAPHIC 190021
3 GRAPHIC proxycard02a.jpg GRAPHIC 152793
  Complete submission text file 0000921895-21-001172.txt   783084
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36866 | Film No.: 21871303
SIC: 2834 Pharmaceutical Preparations